A "living drug" Qartemi has been approved for blood cancer patients in India who suffer from an advanced or relapsed stage of ...

The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...

Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.

The RBI, had in March 2020, rolled out regulatory guidelines for the implementation of Indian Accounting Standards (Ind AS) ...

Syngene International revised its revenue expectations due to further delays in the US biotech funding environment during the third quarter.

Syngene International slumped 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Syngene International declined 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Life is unpredictable, and while we can’t foresee the future, we can prepare for it. One of the best ways to protect yourself and your finances from life’s surprises is by having an emergency fund. In ...

The company is confident of continuing to expand at over 30% growth rate, and said the retail participation too has been ...

Pune: While speaking on 67 cases of Guillain-Barre Syndrome (GBS) reported in Pune district, Assistant Health Officer, Pune Municipal Corporation Vaishali Jadhav said that a total of 67 cases of ...

This auto outperformer has respected its upward-sloping trend line on the monthly frame. It has made a bottom on weekly frame and the halt at the support zones makes up for a good base. Traders can ...

US President Donald Trump announced the formation of a committee to develop a regulatory framework for digital assets, led by David Sacks. The executive order aims to advance America's crypto ...